Sort by
Refine Your Search
-
. It aligns with the Programme for Government 2024–2027 and positions the region as a leader in equitable, multilingual governance. The project’s outcomes—evidence-based policy recommendations
-
contribute to the evidence base for public health policy, inform future treatment strategies, and support the wider Programme for Government aim of enabling people to live long, healthy, and active lives
-
to be used, fabrication methods, radiation modelling, and computational fluid dynamics. Bench scale reactors will be fabricated and tested in the lab for the removal of CECs in simulated wastewater
-
for innovation, productivity and internationally orientation in the NIE Programme for Government and are one of seven sector specific action plans (DfE 2024). Data on Creative Industries’ (CI) participation
-
Summary Positioned within Ulster University’s School of Computing, this research theme focuses on harnessing artificial intelligence and spectral technologies to strengthen food integrity and
-
applicants from diverse academic and professional backgrounds, including (but not limited to): Film, Television, and Media Studies Artificial Intelligence and Computer Science Creative Arts and Practice-based
-
waiting lists, support and optimise programme uptake and outcomes, using observational questionnaires and exit interviews. Methods An in-depth analysis of existing Pulmonary Rehabilitation programmes in
-
programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part
-
Development of smart clothing for physiological monitoring of children with heart conditions at home
programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part
-
Summary Applicants are invited to undertake a 3 year PhD program in partnership with a global leader in blood- and cell-based therapies (Terumo Blood and Cell Technologies Ltd). This opportunity